Medtronic constant blood monitoring devices approved for kids

03/13/2007 | Pioneer Press (St. Paul, Minn.) · Bloomberg Businessweek

Medtronic received FDA approval for its Guardian Real-Time System glucose monitor and its Paradigm Real-Time System insulin pump that incorporate blood sugar monitoring technology for use in those aged 7 to 17. The devices work by placing sensors under the skin to constantly monitor blood sugar levels.

View Full Article in:

Pioneer Press (St. Paul, Minn.) · Bloomberg Businessweek

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA